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Carotid intima-media thickness (cIMT) is an established heritable marker for subclinical
atherosclerosis. In this study, we aim to identify rare variants with large effects driving
differences in cIMT by performing genome-wide linkage analysis of individuals in the
extremes of cIMT trait distribution (>90th percentile) in a large family-based study from
a genetically isolated population in the Netherlands. Linked regions were subsequently
explored by fine-mapping using exome sequencing. We observed significant evidence
of linkage on chromosomes 2p16.3 [rs1017418, heterogeneity LOD (HLOD) = 3.35],
19q13.43 (rs3499, HLOD = 9.09), 20p13 (rs1434789, HLOD = 4.10), and 21q22.12
(rs2834949, HLOD = 3.59). Fine-mapping using exome sequencing data identified a
non-coding variant (rs62165235) in PNPT1 gene under the linkage peak at chromosome
2 that is likely to have a regulatory function. The variant was associated with
quantitative cIMT in the family-based study population (effect = 0.27, p-value = 0.013).
Furthermore, we identified several genes under the linkage peak at chromosome
21 highly expressed in tissues relevant for atherosclerosis. To conclude, our linkage
analysis identified four genomic regions significantly linked to cIMT. Further analyses are
needed to demonstrate involvement of identified candidate genes in development of
atherosclerosis.
Keywords: atherosclerosis, intima-media thickness, genetics, linkage, exome sequencing
INTRODUCTION
Cardiovascular diseases, including heart and cerebrovascular diseases, are listed among the leading
causes of death in developed countries (Xu et al., 2016). The underlying pathology in the majority of
cases is atherosclerosis (Falk, 2006). cIMT, a quantitative measure of carotid artery wall thickening,
is a marker for subclinical atherosclerosis that has been shown to predict future cardiovascular
Abbreviations: BMI, body mass index; CADD, Combined Annotation-Dependent Depletion; cIMT, carotid intima-media
thickness; ERF, Erasmus Rucphen Family; HLOD, heterogeneity logarithm of the odds; HWE, Hardy–Weinberg equilibrium;
1kG, 1000 Genome Project; LOD, logarithm of the odds; MAF, minor allele frequency; NPL, non-parametric linkage; PCOS,
polycystic ovary syndrome; POAG, primary open-angle glaucoma; SNV, single nucleotide variant; WHR, waist–hip ratio.
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events in large epidemiological studies (Lorenz et al., 2007;
Polak et al., 2011; Den Ruijter et al., 2012). cIMT is determined
by both traditional cardiovascular risk factors, such as aging,
blood pressure, BMI, plasma lipid levels, diabetes mellitus or
smoking, and genetic factors (Lusis, 2012). Genetic factors play
a key role in the etiology of cIMT with heritability estimates
ranging from 30–60% (Fox et al., 2003; Sacco et al., 2009). Several
genome-wide linkage studies of quantitative cIMT published up
to date reported significant and suggestive evidence of linkage
on chromosomes 2q33-q35, 6p12-p22, 7p, 11q23, 12q24, 13q32-
q33, and 14q31 (Fox et al., 2004; Wang et al., 2005; Sacco
et al., 2009; Kuipers et al., 2013). The largest genome-wide
association study (GWAS) of cIMT, including 42,484 individuals,
identified only three genomic regions of common non-coding
genetic variation on 8q24 (near ZHX2), 19q13 (near APOC1),
and 8q23.1 (PINX1) and an additional suggestive region on 6p22
(near SLC17A4; Bis et al., 2011). In addition, an exome-wide
association study in 52,869 individuals identified the association
of protein-coding variants in APOE with cIMT (Natarajan et al.,
2016). The identified variants provide valuable insights into the
genetic architecture of cIMT but explain a small proportion
of the trait variance (Bis et al., 2011). A previous sequencing
study of cIMT candidate regions in population-based cohorts
yielded inconclusive results due to limited power (Bis et al.,
2014). A more powerful approach for uncovering the role of
rare variants is a family-based study design due to the higher
frequency of the rare variants (Auer and Lettre, 2015). The
chances of success for family-based studies are even higher in
genetic isolates since rare variants become more frequent due to
founder effect, genetic drift, and inbreeding (Stacey et al., 2011;
Gudmundsson et al., 2012; Auer and Lettre, 2015).
In this study, we hypothesized that there may be rare variants
with large effects driving differences in cIMT independently of
traditional cardiovascular risk factors and that these variants
are enriched in the extremes of the cIMT distribution.
To the best of our knowledge, no study to date explored
extremes of quantitative cIMT. However, this approach has been
demonstrated as successful for some other quantitative traits.
Following the same approach as described in our study, Amin
et al. (2018) successfully identified a rare variant of large effect in
large extended families. To discover such variants in the extremes
of cIMT distribution, we performed affected-only genome-wide
linkage analysis of cIMT followed by fine-mapping using exome
sequencing in a large family-based study from a genetically
isolated population in the Netherlands.
MATERIALS AND METHODS
Study Population
Our study population consisted of participants from ERF
study. ERF is a family-based cohort that includes around 3,000
inhabitants of a genetically isolated community in the South-
West of Netherlands (Pardo et al., 2005). The community was
constituted as a religious isolate at the middle of the 18th century
by a limited number of founders (Pardo et al., 2005). The
population has remained in isolation with minimal immigration
rate and high inbreeding (Aulchenko et al., 2004; Pardo et al.,
2005). All ERF participants are living descendants of a limited
number of founders living in the 19th century. The Medical
Ethical Committee of the Erasmus University Medical Center,
Rotterdam, approved the study. Written informed consent was
obtained from all participants.
Phenotypes
Participants from ERF underwent extensive clinical examination
between 2002 and 2005. cIMT was measured using high-
resolution B-mode ultrasonography with a 7.5-MHz linear array
transducer (ATL UltraMark IV). Maximum cIMT was measured
on the three still, longitudinal, two-dimensional ultrasound
images of the near and far wall from both left and right arteries,
as described previously (Sayed-Tabatabaei et al., 2005). The mean
value of these measurements was used for the analyses.
Information on covariates included age, sex, and smoking
status. BMI was defined as weight divided by the square of height
(kg/m2) and WHR was computed by dividing the waist and
hip circumferences with each other. Hypertension was defined
as systolic blood pressure above 140 mmHg, diastolic blood
pressure above 90 mmHg, or use of medication for treatment of
hypertension. Dyslipidemia was defined as total cholesterol above
6.2 mmol/L or use of lipid-lowering medication, whereas diabetes
was defined as fasting plasma glucose levels above 7 mmol/L,
random plasma glucose above 11.1 mmol/L, or use of medication
indicated for treatment of diabetes.
Genotyping
Genotyping on the Illumina 6K Array
Genomic DNA was extracted from peripheral venous blood of
all study participants using the salting out procedure (Miller
et al., 1988). Genotyping was performed using the 6K Illumina
Linkage IV Panels (Illumina, San Diego, CA, United States) at
the Centre National de Genotypage in France. Markers with a
MAF < 5%, call rate < 98%, or which failed an exact test of
HWE (p-value < 10−8) were removed during the quality control
process. In total, 5,250 autosomal variants were available for
analysis.
Exome Sequencing
The exomes of randomly selected participants from the ERF
study were sequenced at the Cell Biology Department of the
Erasmus University Medical Center, Rotterdam. Sequencing was
performed at a median depth of 57× using the Agilent version
V4 capture kit on an Illumina Hiseq2000 sequencer using the
TruSeq Version 3 protocol (Amin et al., 2016, 2017a). After
quality control, we retrieved 528,617 SNVs in 1,308 individuals,
of which 1,046 had cIMT data available. Annotation of the
SNVs was performed using the SeattleSeq annotation database1.
To further assess the functionality of the variants, we used
RegulomeDB database that annotates SNVs with known and
predicted regulatory elements and CADD tool for scoring the
deleteriousness of variants (Boyle et al., 2012; Kircher et al.,
1http://snp.gs.washington.edu/SeattleSeqAnnotation138/
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2014). The ERF data are available in the European Genome-
phenome Archive (EGA) public repository with ID number
EGAS00001001134.
Statistical Analysis
Linkage Analysis
We performed affected only genome-wide multipoint NPL
analysis in MERLIN 1.1.2 using individuals from the ERF study
(Abecasis et al., 2002). Individuals that scored above the 90th
percentile of the distribution of the residuals from the regression
of cIMT onto age, age2, sex, smoking status, BMI, WHR,
diabetes, dyslipidemia, and hypertension were set as affected
(N = 103). Descriptive characteristics of the selected individuals
are presented in Table 1. The selected individuals were older
and higher cIMT measurements compared to all ERF study
participants (Table 1). They also had a higher prevalence of
hypertension, dyslipidemia, and diabetes than all ERF study
participants, whereas the BMI and WHR were comparable
(Table 1). These 103 affected individuals were connected to
each other in a large pedigree consisting of 5,083 individuals.
To facilitate linkage analysis, the 103 affected individuals were
clustered into 21 smaller non-overlapping sub-pedigrees with a
maximum bit size of 24 using the PEDCUT software version
1.19 (Liu et al., 2008). Bit size value is used to characterize the
maximal number of subjects of interest who share a common
ancestor (Liu et al., 2008). The number of affected subjects
of interest in the sub-pedigrees ranged from two to eight.
MEGA2 software tool version 4.4 (Baron et al., 2014) was used
to create input files for MERLIN. Mendelian inconsistencies
were set to missing within the whole sub-pedigree. There were
543 Mendelian inconsistencies observed among 5,250 autosomal
variants. After they were set to missing, 4,707 autosomal
TABLE 1 | Descriptive statistics of study populations including ERF cases
(N = 103) selected for the linkage analysis and ERF overall.
Characteristics ERF cases ERF overall
Age, mean (SD) 53.6 (13.6) 48.3 (14.2)
Gender, % of males 45.6% 40.2%
cIMT (mm), mean (SD) 1.1 (0.2) 0.8 (0.2)
Smoking, % of ever
smokers
44.7% 41.9%
BMI (kg/m2), mean (SD) 26.9 (3.7) 26.7 (4.4)
WHR, mean (SD) 0.9 (0.1) 0.9 (0.1)
Hypertension, % of cases
with hypertension
63.1% 48.7%
Dyslipidemia, % of cases
with dyslipidemia
51.5% 36.2%
Diabetes, % of patients
with diabetes
6.8% 4.5%
cIMT, carotid intima-media thickness; BMI, body mass index; WHR, waist to hip
ratio; hypertension, systolic blood pressure above 140 mmHg, diastolic blood
pressure above 90 mmHg, or use of medication for treatment of hypertension;
dyslipidemia, total cholesterol above 6.2 mmol/L, or use of lipid-lowering
medication; diabetes, fasting plasma glucose levels above 7 mmol/L, random
plasma glucose above 11.1 mmol/L, or use of medication indicated for the
treatment of diabetes.
variants were used in the linkage analysis. We also performed
affected only parametric linkage analysis under the dominant
and recessive models assuming incomplete penetrance of 0.5
and a disease allele frequency of 0.01 using MERLIN. Marker
allele frequencies were calculated from all genotyped individuals
in the pedigrees. Subsequently, we carried out per family
analyses in order to identify families that were contributing
predominantly to the linkage signals, henceforth referred to
as “contributing families.” Additionally, we performed variance
component linkage analysis in MERLIN using quantitative cIMT
in the total study population. To facilitate analysis, PEDCUT
software was used to cluster individuals into 116 non-overlapping
sub-pedigrees. The number of subjects of interest in the sub-
pedigrees ranged from 2 to 18. To determine the significance
of each test, the LOD score was calculated as the log10 of the
likelihood ratio. The LOD score of 3.3 or higher was considered
to represent genome-wide significance threshold, whereas the
LOD score of 1.9 was used to declare genome-wide suggestive
threshold (Ott et al., 2015).
Identification of Variants Under the Linkage Peaks
Using Exome Sequencing
We used exome sequence data to identify variants that could
explain observed linkage peaks. To this end, we looked for
variants that were shared among the majority of affected
individuals from the contributing families within the respective
linkage peak. We only considered variants with MAF < 5%
or absent in 1kG and MAF < 5% in the ERF controls which
were defined as individuals who scored below the mean of the
distribution of the residuals from the regression of cIMT onto
age, age2, sex, smoking status, BMI, WHR, diabetes, dyslipidemia,
and hypertension. The MAF of variants absent in 1kG project
was checked in NHLBI Exome Sequencing Project2. Candidate
variants were subjected to quantitative trait association analysis
with cIMT in the ERF under the same model as in the
sharing analysis (additive, dominant, recessive) using the RVtests
software (Zhan et al., 2016). Inverse normalized residuals from
the regression of cIMT onto age, age2, sex, smoking status, BMI,
WHR, diabetes, dyslipidemia, and hypertension were used in the
association analysis. To take into account multiple tests, we first
calculated a number of independent tests using the method of
Li and Ji (2005). Subsequently, Bonferroni corrected p-value was
calculated based on number of independent tests. GTEx portal3
was used to check for gene expression.
RESULTS
The results of affected only genome-wide NPL and parametric
linkage scans are illustrated in Figure 1. Regions with significant
(LOD > 3.3) evidence of linkage in either the non-parametric or
the parametric analyses are shown in Table 2. Significant evidence
of linkage for cIMT was observed to chromosomes 2p16.3,
19q13.43, 20p13, and 21q22.12 in the parametric linkage analysis
2http://evs.gs.washington.edu/EVS/
3https://www.gtexportal.org/home/
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FIGURE 1 | The results of genome-wide linkage scan for non-parametric (blue) and parametric analyses under the dominant (green) and recessive (red) models. The
x-axis shows 22 autosomal chromosomes, whereas the y-axis shows the LOD scores for non-parametric model and heterogeneity LOD (HLOD) scores for dominant
and recessive model. Black dotted line depicts the genome-wide significant threshold, whereas gray dotted line shows the suggestive threshold.
TABLE 2 | Genome-wide significant results of linkage analyses for cIMT.
Region Start SNV End SNV Start
position∗
End position∗ SNV with max
LOD
Dominant
(HLOD)
Recessive
(HLOD)
Non-parametric
(LOD)
2p16.3 rs1447107 rs1017267 45272197 56785785 rs1017418 3.35 2.88 1.40
19q13.43 rs897783 rs3499 52031162 59093484 rs3499 7.17 9.09 3.73
20p13 rs1434789 rs241605 137900 3915064 rs1434789 4.10 3.87 3.34
21q22.12 rs762173 rs2836803 33832675 40351780 rs2834949 3.59 1.86 2.14
SNV, single nucleotide variant; HLOD, heterogeneity LOD.
Regions with significant evidence of linkage are in bold.
∗Start and end positions correspond to genetic position of SNV at the start or end of the base to base linkage region according to hg19 assembly. Start and end SNVs
are reported for base to base linkage regions.
under the dominant model, and to chromosome 19q13.43 and
20p13 in the parametric linkage analysis under the recessive
model. The families contributing predominantly to these linkage
peaks and the distribution of their per-family HLOD scores are
shown in Supplementary Figures S1–S4.
We next determined to what extent the affected members
in these families shared rare variants under the linkage
peaks. Sharing analyses under the base to base linkage peak
at chromosome 2 (family specific HLOD = 3.63) identified
intronic and coding-synonymous variants (Table 3). The most
interesting finding is a variant (rs62165235) with MAF 0.038
in 1kG mapping to PNPT1. The variant, shared by six out of
eight affected relatives, is likely having a regulatory function
and affecting transcription factor binding and matched DNase
Footprinting and DNase sensitivity (Category 2b Regulome DB
score; Tables 3, 4). The variant was sequenced at a read depth
of 37x and it showed significant association with quantitative
cIMT in the ERF (effect = 0.27, p-value = 0.013, Table 3) after
applying Bonferroni correction (p-value = 0.05/3 independent
tests = 0.017). The effect estimate of the minor allele C on
untransformed cIMT suggested a mean increase of 0.04 mm for
each minor allele (0.04 mm for heterozygote C/T carriers and
0.08 mm for homozygous C/C carriers; Table 3). This variant
explained 0.3% of variation in the ERF.
The search for shared variants within the linkage regions at
chromosome 19, 20, and 21 identified several variants to be
shared among the affected family members; however, none of the
variants showed significant association with quantitative cIMT
(Supplementary Tables S1–S3). There are, however, several
potentially interesting candidate genes for atherosclerosis in each
of these linked regions, for instance, among the genes under the
base to base linkage peaks at chromosome 19 and 20, several
genes have been implicated in the pathogenesis of cardiovascular
disease, including FCAR, TNNT1, OSCAR, FPR2 under the peak
at chromosome 19 and ADAM33, TRIB3, HSPA12B under the
peak at chromosome 20. The linkage peak at chromosome 21
harbors several genes that are highly expressed in tissues relevant
for atherosclerosis (e.g., vascular, liver, kidney, gastrointestinal,
and adipose tissue; Ramsey et al., 2010), including IFNAR1,
DYRK1A, SON, IFNGR2, MORC3, MRPS6, IL10RB, TMEM50B,
CBR1, RCAN1, and TTC3 (Figure 2). According to the Ingenuity
Pathway Analysis (IPA) tool (QIAGEN Inc.4), which exposes
possible functional relationship between the genes by expanding
upstream analysis to include regulators that are not directly
connected to targets in the dataset, these genes connected to a
network illustrated in Supplementary Figure S5.
There were several regions that showed suggestive evidence
of linkage, including 1q31.1, 5q35.3, 7p21.3, 8p22, 12q24.33,
14q22.2, 15q21.3, and 17q25.3. As the region at chromosome 12
has previously been linked to cIMT, we have explored it further
(Figure 1). Search for shared variants within this region identified
no variants that can explain linkage signal.
The results of linkage analysis when using cIMT as a
quantitative outcome are shown in Supplementary Figure S6.
DISCUSSION
In this study, we have identified genomic regions at 2p16.3,
19q13.43, 20p13, and 21q22.12 with significant evidence of
linkage to cIMT. These regions have not been reported before.
4https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/
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TABLE 3 | Variants shared among the affected family members of the family that predominantly contributed to the LOD score at chromosome 2.
Name∗ Function Gene MAF ERF
controls∗∗
MAF
1kG∗∗∗
CADD Regulome
DB
Effect
allele
Association analysis in ERF
Beta Betauntransformed SE P
rs375801385 Intron FBXO11 0.031 0.056 17.18 6 T 0.023 0.014 0.145 0.876
2:48848294 Intron GTF2A1L 0.031 NA 5.82 – C 0.023 0.014 0.145 0.876
rs149304214 Coding-
synonymous
SPTBN1 0.016 0.002 15.95 – T 0.311 0.059 0.182 0.087
rs62165235 Intron PNPT1 0.044 0.038 4.41 2b C 0.265 0.037 0.107 0.013
rs114706375 Intron USP34 0.026 0.010 0.12 5 C 0.124 0.036 0.145 0.393
rs144629927 Intron XPO1 0.021 0.003 4.60 3a G 0.131 0.041 0.159 0.409
MAF, minor allele frequency; 1kG, 1000 Genomes; CADD, Combined Annotation-Dependent Depletion score; Regulome DB, Regulome DB score; beta, effect estimate;
betauntransformed, effect estimate from association analysis in which untransformed cIMT was used; SE, standard error of beta; P, p-value; ERF, Erasmus Rucphen Family
study. ∗The variants are ordered based on their genomic position (hg19 assembly). First four variants are shared by 6 of 8 affected family members in a family contributing
predominately to the linkage peak, and last two variants are shared by five of eight affected family members.
∗∗ERF controls were defined as individuals who scored below the mean of the distribution of the residuals from the regression of cIMT onto age, age2, sex, smoking
status, BMI, WHR, diabetes, dyslipidemia, and hypertension.
∗∗∗ If MAF was unknown in 1kG, MAF reported from Exome Sequencing Project if available.
TABLE 4 | Functional annotation of rs62165235 variant and variants that are in LD (r2 > 0.6) using HaploReg 4.1 (Ward and Kellis, 2012).
Variant LD (r2) Ref Alt GERP
cons∗
Promoter
histone
marks
Enhancer
histone
marks
DNAse Proteins
bound
Motifs
changed
Selected
eQTL hits
RefSeq
genes
Function
rs7591128 0.65 T G No – BLD – – Six altered
motifs
One hit 39 kb 5′ of
CCDC88A
Intergenic
rs78928997 0.75 T A Yes – – – – Seven altered
motifs
– SMEK2 3′-UTR
rs62165193 0.77 C T No – Two
tissues
– – GR – SMEK2 Intronic
rs62165227 0.61 G A No – – – – – – PNPT1 Intronic
rs62165231 0.95 C T No – – HRT – Rad21,Tgif1 One hit PNPT1 Intronic
rs62165235 1 T C No 24
tissues
– 15tissues E2F6 Seven altered
motifs
– PNPT1 Intronic
rs62165236 0.96 T C No – – – – ZID – 2.1 kb 5′
of PNPT1
Intergenic
rs79873145 0.76 T C No – GI – – Four altered
motifs
One hit 30 kb 5′
of PNPT1
Intergenic
Ref, reference allele; Alt, alternative allele; GERP, conservation score. ∗GERP conservation score indicates whether the element is conserved or not according to the
algorithm. The variant highlighted in red was identified in the sharing and association analysis in the ERF.
Identification of variants under the linkage peaks using exome
sequencing revealed a variant with likely regulatory function
mapping to PNPT1 gene at chromosome 2 and several candidate
genes at chromosome 21.
As the present study targets genes with relatively large
effects, we studied the extremes of cIMT distribution in the
discovery population. Even though extreme trait approach
neglects much of the overall distribution of the trait and
some rare variants with the moderate effects may be missed,
it has been shown that the power to detect rare variants can
be increased due to an excess of rare variants in the upper
tails of the distribution (Coassin et al., 2010; Lamina, 2011;
Auer and Lettre, 2015). Comparison of the results obtained
in the linkage analysis of the extremes of cIMT distribution
and those using cIMT as a quantitative trait revealed no
overlap, highlighting the power of the approach we have
followed.
When comparing the results of several genome-wide linkage
studies of cIMT that have been conducted so far, we noticed
that a region with suggestive evidence of linkage in our study
at chromosome 12 has previously been linked to cIMT through
the linkage scan (Fox et al., 2004). Similarly to the previous study
which identified 12q24, we did not identify variants by sharing
analysis that could explain the linkage signal. Even though
linkage findings from prior studies already showed limited
generalizability across the reported linkage peaks due to selected
nature of the cohorts, the overlap of our finding with the literature
suggests that our study population is representative of the general
population. However, the linkage signal at chromosome 12 is
relatively weak in our population.
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FIGURE 2 | Genes under the base to base linkage peak at chromosome 21 and their expression levels in tissues relevant for atherosclerosis according to GTEx
database. Gene names are shown on y-axis and tissues on x-axis. Color depicts expression level estimated as fragments per kilobase of exon model per million
reads mapped (FPKM). The gray box stands for expression level below cutoff (0.5 FPKM), light blue box stands for low expression level (between 0.5 and 10),
medium blue for medium expression level (between 11 and 1000 FPKM), dark blue for high expression level (more than 1000 FPKM or more than 1000 TPM), and
white for no data available.
Among the regions with significant evidence of linkage to
cIMT in our study, we identified 2p16.3 which gave significant
linkage signal under the dominant model and suggestive signal
under the recessive model. This region has previously been
associated with PCOS and POAG (Liu et al., 2010; Mutharasan
et al., 2013). Interestingly, women with PCOS are at a greater
risk of premature atherosclerosis (Meyer et al., 2012), whereas
atherosclerosis is associated with vascular conditions that are
correlated with POAG (Belzunce and Casellas, 2004). The region
has further been implicated in BMI (Akiyama et al., 2017) and
glycated hemoglobin levels (Wheeler et al., 2017). Both obesity
and poor glycemic control are risk factors for variety of diseases
including atherosclerosis and cardiovascular diseases.
Identification of variants under the base to base peak at
chromosome 2 using exome sequence data revealed a variant that
lies in DNase sites, promotes histone marks and protein binding
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regions, and changes regulatory motifs based on the variant allele
change. The variant is mapped to intron 1 of polyribonucleotide
nucleotidyltransferase 1 (PNPT1) gene which encodes a protein
predominantly localized in the mitochondrial intermembrane
space and is involved in import of RNA to mitochondria5.
PNPT1 has been characterized as a type I interferon-inducible
early response gene (Leszczyniecka et al., 2002, 2003). Type I
interferons promote atherosclerosis by enhancing macrophage-
endothelial cell adhesion and promoting leukocyte attraction to
atherosclerosis-prone sites in animal models (Goossens et al.,
2010). Even though our finding supports a role of PNPT1
as a candidate gene in atherosclerosis, we acknowledge that
PNPT1 variant is unlikely to be causal and cannot explain
the linkage signal at chromosome 2 to cIMT. Furthermore,
we attempted to replicate the association of this variant with
cIMT in the Rotterdam Study, a population-based cohort study
(detailed information is provided in Supplementary Material
and Supplementary Table S4). However, the variant was not
available in the exome sequencing data of the Rotterdam Study.
The other interesting region includes the linkage peak at
chromosome 21 which is also known as a Down critical region.
Interestingly, persons with Down syndrome are protected against
atherosclerosis, in spite of increases in metabolic disturbances
and obesity in Down syndrome (Colvin and Yeager, 2017).
Even though identification of variants using exome sequencing
did not identify a causal variant, this region contains several
plausible candidate genes which are highly expressed in relevant
tissues (Ramsey et al., 2010), including IFNAR1, DYRK1A, SON,
IFNGR2, MORC3, MRPS6, IL10RB, TMEM50B, CBR1, RCAN1,
and TTC3. DYRK1A signaling pathway is linked to homocysteine
cycle which is associated with an increased risk of atherosclerosis
(Noll et al., 2009; Tlili et al., 2013). IFNGR2 and RCAN1 also play
a role in atherosclerosis (Mendez-Barbero et al., 2013; Voloshyna
et al., 2014). Notably, IPA analysis revealed that those genes are
connected in one network, and directly or indirectly linked to
TP53. TP53 encodes a tumor suppressor gene p53 involved in
regulation of cell proliferation and apoptosis. Numerous studies
implicated p53 in development of atherosclerosis and vascular
smooth muscle cell apoptosis (Tabas, 2001; Mayr et al., 2002;
Mercer et al., 2005; Boesten et al., 2009; Varela et al., 2015). Higher
plasma p53 levels were also associated with an increased cIMT
(Chen et al., 2009). However, it is important to note that network
analysis is based on the knowledge databases that are always
evolving and new discoveries happen all time.
Furthermore, we identified 19q13.43 and 20p13 regions with
significant evidence of linkage to cIMT. Several genes under the
linkage peak have previously been implicated in the pathogenesis
of cardiovascular disease. The base to base peak at chromosome
19 encompassed FCAR and TNNT1 genes associated with
coronary heart disease (Iakoubova et al., 2006; Guay et al., 2016)
and OSCAR and FPR2 genes associated with atherosclerosis
plaque phenotype (Goettsch et al., 2011; Petri et al., 2015),
whereas the base to base peak at chromosome 20 encompassed
ADAM33 and TRIB3 associated with extent and promotion of
atherosclerosis (Holloway et al., 2010; Formoso et al., 2011; Wang
5http://www.genecards.org/cgi-bin/carddisp.pl?gene=PNPT1
et al., 2012; Figarska et al., 2013; Prudente et al., 2015) and
HSPA12B which is found to be enriched in atherosclerotic lesions
(Han et al., 2003).
Our study presents the linkage analysis using extreme
phenotype approach that was designed to capture region with
genetic variants that have large effects on cIMT. Combination of
linkage analysis in a large family-based study and exome sequence
data provide a unique opportunity to explore the variants in the
linkage regions. However, despite these distinct advantages, we
were able to identify a genetic variant for only one of the several
linked genomic regions, for which, there may be several reasons
including structural variants, and intronic or intergenic single-
nucleotide variants that were not evaluated in the current study.
Interestingly, the 19q13.43, 20p13, and 21q22.12 linkage peaks
were previously associated with various phenotypes in our study
population including personality traits and depressive symptoms
(Amin et al., 2012, 2017b).
CONCLUSION
Our linkage analysis identified four genomic regions at 2p16.3,
19q13.43, 20p13, and 21q22.12 for cIMT. The significant
linkage regions contain several plausible candidate genes. Further
analyses are needed to demonstrate their involvement in
atherosclerosis.
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